| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.11B | -1.7% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 30.3% | Net margin -5.7% |
| Revenue Q/Q | +0.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 69.7% |
| R&D | ¥0.01B | 5.4% |
| SG&A | ¥0.04B | 32.6% |
| Tax & other | ¥-0.00B | -0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
兴齐眼药 ・ 中旗股份 ・ 容大感光 ・ 开润股份 ・ 会畅科技 ・ 数字认证 ・ 贝斯特 ・ 晨曦航空 ・ 英飞特 ・ 赛托生物 ・ 海辰药业 ・ 奥联电子
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies